Publicaciones en colaboración con investigadores/as de Centro Nacional de Investigaciones Oncológicas (14)

2026

  1. Prognostic Value of Blood Epigenetic Biomarkers of Aging in Persons With Well-Controlled HIV-1 Infection

    Clinical Infectious Diseases, Vol. 82, Núm. 4, pp. 583-591

2025

  1. Convergent Genetic Adaptation in Human Tumors Developed Under Systemic Hypoxia and in Populations Living at High Altitudes

    Cancer discovery, Vol. 15, Núm. 5, pp. 1037-1062

  2. Expression of Homo Sapiens (Hsa)-miR-139-5p as a Clinically Feasible Prognostic Marker for Differentiated Thyroid Cancer

    Laboratory Investigation, Vol. 105, Núm. 10

  3. Significant attenuation of fully automated thrombin generation in newly diagnosed multiple myeloma patients after induction therapy

    Journal of Thrombosis and Thrombolysis, Vol. 58, Núm. 3, pp. 467-480

  4. p53 protein degradation redefines the initiation mechanisms and drives transitional mutations in colorectal cancer

    Nature Communications , Vol. 16, Núm. 1

2024

  1. Mapping the Spatial Dynamics of the CD4+ T Cell Spectrum in Classical Hodgkin Lymphoma

    Modern Pathology, Vol. 37, Núm. 9

  2. Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH)

    Gastroenterologia y Hepatologia

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study

    Cancer, Vol. 129, Núm. 5, pp. 697-713

2021

  1. LungBEAM: A prospective multicenter study to monitor stage IV NSCLC patients with EGFR mutations using BEAMing technology

    Cancer Medicine, Vol. 10, Núm. 17, pp. 5878-5888

  2. Tumor mutational burden assessment in non-small-cell lung cancer samples: Results from the TMB 2 harmonization project comparing three NGS panels

    Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 5

2020

  1. Development and validation of the gene expression predictor of high-grade serous ovarian carcinoma molecular SubTYPE (PrOTYPE)

    Clinical Cancer Research, Vol. 26, Núm. 20, pp. 5411-5423

  2. Mutational Screening of BRCA1/2 Genes as a Predictive Factor for Therapeutic Response in Epithelial Ovarian Cancer: A Consensus Guide from the Spanish Society of Pathology (SEAP-IAP) and the Spanish Society of Human Genetics (AEGH)

    Virchows Archiv, Vol. 476, Núm. 2, pp. 195-207

2019

  1. Comparing the influence of two immunosuppressants (fingolimod, azathioprine) on wound healing in a rat model of primary and secondary intention wound closure

    Wound Repair and Regeneration, Vol. 27, Núm. 1, pp. 59-68